Navigation Links
Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
Date:2/20/2008

reflects the ongoing effort of all our employees, we will continue to focus on improving our profitability," commented Dan Moore, Cyberonics' President and Chief Executive Officer. "Secondly, our domestic epilepsy business is growing, as evidenced by a 9% growth in units sold, and revenue growth of approximately 13%, over the third quarter of FY07. We continue to enjoy strong growth in our international business, which delivered 34% growth in epilepsy revenue. Globally, epilepsy revenue grew by 17% over the prior year. While our January price increase had little impact on the recently completed quarter, we expect it to contribute more significantly in future periods.

"After consulting with clinical and reimbursement experts, we have developed a plan for our depression indication. We have also engaged an investment bank to find a financial partner to assist in execution of the plan, which includes the possible transfer of the depression indication to a separate entity in which we expect to maintain at least a minority interest.

"The licensing activity that we announced in December is a clear indication of our progress toward our fourth objective. We intend to continue to seek appropriate partnership opportunities.

"Our balance sheet, particularly our cash position, has improved over the course of the year, and at the appropriate time, will provide management with resources to enhance the value of the company to shareholders.

"The share repurchase program underscores our ongoing commitment to increase shareholder value and the Board's confidence that we are poised for future growth. Overall, we made solid progress on all fronts, strengthening the company's position in the neuromodulation device business sector. We expect this progress to continue."

Additional details of progress toward objectives and sales by geography, indication, and product line will be provided during the upcoming conference call and in the accompanying presenta
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 On Saturday, May 2nd, 2015, ... of his team from Georgia Eye Physicians and ... Lupus Now, being held in Piedmont Park by the ... to be the largest LFA-sponsored walk in the nation, ... raise funds and awareness for lupus, an unpredictable and ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 When author ... (CFS), she felt as if nothing could wake her ... estimates that 250,000 U.K. citizens are currently living with CFS. ... action. Her new book, “ Living a Life Less Toxic ... Home, and Environment. Create a Happier, Healthier Life for You, ...
(Date:4/20/2015)... 21, 2015 Reality show stars, food, ... at the twentieth annual Michigan International Women’s Show, April ... , “There is lots to see and do from ... for fashion and gifts,” said Beth Anderson, executive show ... and encouraging with appearances from Randy Fenoli of ‘Say ...
(Date:4/20/2015)... 2015 Saint Joseph Regional Medical Center (SJRMC) ... Systems by Truven Health Analytics, a leading provider of information ... SJRMC has been recognized by Truven Health Analytics as a ... years. , According to Truven Health Analytics' analysis ... matchups with their peers, set the standard for care in ...
(Date:4/20/2015)... At the famous Avalon Hollywood on ... Awards” EcoLuxe Lounge, with Choices Recovery as the premier ... sustainable product placement in TV and film, gathered some ... ecologically sound goods and services for this daylong event. ... the Choices Celebrity Interview Lounge, speaking with many of ...
Breaking Medicine News(10 mins):Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2
... Boston, Massachusetts has come out with findings that oral ... in a better way. ,Listing cases ... in the research, Dr Lawrence Shulman, of the Dana-Farber ... a consensus in the oncology field on standardized safeguards ...
... may be a case of being patronized, but Health Minister Andy ... ,Kerr is backing a 2.5 million pound campaign that will begin ... hands more often and this way combat the common cold, flu, ... MRSA. ,Says Kerr ‘It's a simple message, but washing ...
... sleep and heart disease is a two-way street: Poor ... can disturb sleep, reports the January 2007// issue of ... been linked with high blood pressure, atherosclerosis, heart failure, ... that ties these together may be inflammation, the body’s ...
... A pilot project that allowed prisoners a safe way to ... ended in September 2006. Now, an AIDS activist has urged ... of tattoo parlors in prison, as a method to check ... nearly 17% of the prisoners go in for tattoos or ...
... Little research exists demonstrating that testosterone is both safe ... dysfunction, reveal Mayo Clinic researchers in two new studies, ... ,Mayo Clinic physicians call for large studies ... when testosterone should be prescribed. ,"One of ...
... from food banks were found to be deficient in nutrients ... health of the deprived in the province, researchers from University ... Journal of Public Health, examined 180 food hampers, sourced from ... finding revealed that 99 per cent of the hampers, meant ...
Cached Medicine News:Health News:Watchdog to Be Set on Oral Chemotherapy, Warns Experts 2Health News:Better ‘Nannying’ Now Than Nev 2Health News:Benefits Of Testosterone Treatment 2
(Date:4/20/2015)... 20, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... for the Phase 1 study of MM-302, a ... cancer.  The results were presented today by Patricia ... session at the 2015 American Association for Cancer ... PA. Data described the safety and ...
(Date:4/20/2015)... April 20, 2015  Sigma-Aldrich Corporation (Nasdaq: ... (CR) Magazine,s list of the 100 Best Corporate ... corporate responsibility performance.  Sigma-Aldrich ranked fifth, its highest ... the list. "We are honored to ... efforts and we are extremely pleased with our ...
(Date:4/20/2015)... April 20, 2015 The preclinical contract research organization ... of drugs and safety testing of medical devices, announces that ... this week,s workshop " Drug Transporters in ADME: From the ... . The title of Dr. Hidalgo,s talk is "Modern ... session entitled "Transporter Tools of the Future." The ...
Breaking Medicine Technology:Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2
... YORK, Oct. 7, 2011 Intellect Neurosciences, Inc. (OTCBB: ... clinical-stage pipeline, and multiple licenses with major pharmaceutical companies ... interview with Dr. Daniel Chain, Ph.D., Chairman and CEO ... Dr. Chain will be discussing the state ...
... Health Solutions, Inc. (NYSE: MHS ) today ... the Silver Award for Best Practices in Health Care ... healthcare accreditation organization, during the URAC 12th Annual Quality ... ) Medco,s program was selected as one ...
Cached Medicine Technology:Intellect Neurosciences CEO to be Featured on Wall Street Reporter 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 3